29 Oct 2021 17:04
Sensyne Health plc('Sensyne' of the 'Company')
Results of Annual General Meeting
Oxford, UK, 29 October 2021: Sensyne Health plc (LSE: SENS), the ethical clinical AI company, is pleased to announce that at the Annual General Meeting ('AGM') held earlier today all resolutions were duly passed. The results of the votes received in advance and at the meeting are summarised below while the full text of the resolutions considered at the AGM are available on Sensyne's website (www.sensynehealth.com).
Results of the vote
Res No. | Votes For | % | Votes Against | % | Votes Total | % of ISC | Votes Withheld* |
1 | 109,388,637 | 100.00% | 0 | 0.00% | 109,388,637 | 66.38% | 0 |
2 | 101,205,237 | 92.52% | 8,183,436 | 7.48% | 109,388,637 | 66.38% | 0 |
3 | 109,350,084 | 100.00% | 0 | 0.00% | 109,350,084 | 66.35% | 38,589 |
4 | 109,384,673 | 99.99% | 4,000 | 0.01% | 109,388,673 | 66.38% | 0 |
5 | 109,350,084 | 99.96% | 38,589 | 0.04% | 109,388,673 | 66.38% | 0 |
6 | 109,350,084 | 100.00% | 0 | 0.00% | 109,350,084 | 66.35% | 38,589 |
7 | 101,723,704 | 92.99% | 7,664,969 | 7.01% | 109,388,673 | 66.38% | 0 |
8 | 109,350,084 | 100.00% | 0 | 0.00% | 109,350,084 | 66.35% | 38,589 |
9 | 109,350,084 | 100.00% | 0 | 0.00% | 109,350,084 | 66.35% | 38,589 |
10 | 109,350,084 | 100.00% | 0 | 0.00% | 109,350,084 | 66.35% | 38,589 |
11 | 109,388,673 | 100.00% | 0 | 0.00% | 109,388,673 | 66.38% | 0 |
12 | 109,388,301 | 99.99% | 372 | 0.01% | 109,388,673 | 66.38% | 0 |
13 | 109,388,173 | 99.99% | 500 | 0.01% | 109,388,673 | 66.38% | 0 |
14 | 109,348,520 | 99.96% | 39,781 | 0.04% | 109,388,301 | 66.38% | 372 |
15 | 109,345,020 | 99.96% | 43,281 | 0.04% | 109,388,301 | 66.38% | 372 |
16 | 109,345,020 | 99.96% | 43,653 | 0.04% | 109,388,673 | 66.38% | 0 |
17 | 109,345,712 | 99.96% | 42,961 | 0.04% | 109,388,673 | 66.38% | 0 |
* A vote withheld is not a vote in law and means the percentage of votes cast for and against excludes withheld votes.
-ENDS-
For more information please contact:
Sensyne Health | |
Lord (Paul) Drayson PhD FREng, Chief Executive Officer Dr Richard Pye, Chief Financial Officer | +44 (0) 330 058 1845 |
Peel Hunt LLP (Nominated Adviser and Joint Broker) | |
Dr Christopher Golden James Steel | + 44 (0) 20 7418 8900 |
Liberum (Joint Broker) | |
Bidhi Bhoma Euan Brown | + 44 (0) 20 3100 2000 |
Consilium Strategic Communications | |
Mary-Jane Elliott Jessica Hodgson CSCSensynehealth@consilium-comms.com | +44 (0) 7780600290 |
SternIR | |
Julie Seidel Julie.seidel@sternir.com | +1 (212) 362-1200 |
About Sensyne Health
Sensyne Health plc is a clinical AI company that works in partnership with global healthcare organisations to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).
For more information, please visit: www.sensynehealth.com